Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07740356

Prevalence of Brief Suicidal Crisis in Psychiatric Settings

France is among the countries with one of the highest suicide rates in the world, far above those of its neighboring countries [Wasserman et al., 2012]. Suicide is the second leading cause of death among 15-24-year-olds, just after road traffic accidents, and the leading cause of death among 25-34-year-olds. Current models emphasize the variability of suicidal trajectories and the possible fluctuation in the duration of suicidal crises: for some individuals, the crisis evolves rapidly and explosively (brief), whereas for others, distress becomes more chronic, often in connection with underlying psychiatric disorders [Stanley, Brodsky, and Monahan, 2023]. In this context, the concept of a 'brief suicidal crisis' is an emerging one in psychiatry. It is characterized by an acute phase of psychological vulnerability, during which the main risk is progression to suicidal behavior, but it remains a temporary and reversible psychic crisis (lasting less than 24 hours). The crisis state is marked by a sudden inability to mobilize one's usual coping resources in the face of difficulties, making the individual highly vulnerable. Nevertheless, this concept has been little described, and a better assessment seems desirable, particularly in populations consulting a psychiatrist. Indeed, around 25% of people who die by suicide had consulted a psychiatrist in the month before their death [Luoma et al., 2002], yet few data are available on this topic.

Primary objective is to assess the prevalence of brief suicidal crisis episodes (lasting less than 24 hours) over the past 12 months among patients attending outpatient psychiatric care and within a sample of patients from a population catchment area in the Clermont-Ferrand region.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

CHU de Clermont-ferrand

Clermont-Ferrand, 63000, France

Location status: Recruiting

About this study

Only one visit to estimate the 12-month prevalence of brief suicidal crises, defined as lasting less than 24 hours, among patients seen in outpatient psychiatric practice and in a population-based sample from the Clermont-Ferrand catchment area.

Secondary objectives are to describe the study population and explore factors potentially associated with brief suicidal crises, including age and sex; to assess psychological pain during brief suicidal crises; to estimate the 12-month prevalence of suicidal crises lasting more than 24 hours; to assess psychological pain during suicidal crises lasting more than 24 hours.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Any adult patient consulting the psychiatrist in his/her office during the recruitment period, regardless of the reason for the consultation, and who has given consent to participate in this study.

Exclusion criteria

  • Minor patients, or patients who refuse to participate in the study.
  • Patients who have already completed the self-administered questionnaires previously (e.g., a second consultation within the same week).
  • Patients unable to understand and complete the self-administered questionnaires (cognitive impairment, difficulty understanding French, etc.).

Treatment and study plan

Primary outcomes

  1. Risk score of brief suicidal crisis

    Time frame: Day 1

    Risque suicidaire de Ducher a (aRSD) scale score for brief suicidal crises. Minimum score 0 maximum score 10 . highter score mean worse outcome

Study contacts

Contact information is provided by the study sponsor or research team.

Pierre-Michel LLORCA, prof

CONTACT

[email protected]

33473752124

ingrid de Chazeron, PhD

CONTACT

[email protected]

33 473754580

Sponsors and collaborators

Lead sponsor

University Hospital, Clermont-Ferrand

Other

Registry information

Acronym: RBSCP

Important dates

Study start
2026
Primary completion
2026
Study completion
2026
First posted
Jul 31, 2026
Registry last updated
Jul 31, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.